Localization of neuropeptide Y in human sympathetic ganglia: correlation with met-enkephalin, tyrosine hydroxylase and acetylcholinesterase

Sex differences in sympathetic gene expression and cardiac neurochemistry in Wistar Kyoto rats

The stellate ganglia are the predominant source of sympathetic innervation to the heart. Remodeling of sympathetic nerves projecting to the heart has been observed in several cardiovascular diseases, and sympathetic dysfunction contributes to cardiac pathology. Wistar Kyoto rats are a common model for the study of cardiovascular diseases, but we lack a profile of the baseline transcriptomic and neurochemical characteristics of their cardiac sympathetic neurons. Most studies of cardiovascular disease have used male animals only, but in the future both male and female animals will be used for these types of studies; therefore, we sought to characterize the transcriptome of male and female stellate ganglia and to correlate that with catecholamine and acetylcholine content in the heart. We have generated a dataset of baseline RNA expression in male and female Wistar Kyoto rat stellate ganglia using RNA-seq, and have measured neurotransmitter levels in heart and stellate ganglia using HPLC and mass spectrometry. We identified numerous gene expression differences between male and female stellates, including genes encoding important developmental factors, receptors and neuropeptides. Female hearts had significantly higher neurotransmitter content than male hearts; however, no significant differences were detected in expression of the genes encoding neurotransmitter synthetic enzymes. Similarly, no statistically significant differences were identified between the sexes in cardiac tyrosine hydroxylase levels.

Peptidergic nerves in the eye, their source and potential pathophysiological relevance

Over the last five decades, several neuropeptides have been discovered which subsequently have been found to be highly conserved during evolution, to be widely distributed both in the central and peripheral nervous system and which act as neurotransmitters and/or neuromodulators. In the eye, the first peptide to be explored was substance P which was reported to be present in the retina but also in peripherally innervated tissues of the eye. Substance P is certainly the best characterized peptide which has been found in sensory neurons innervating the eye. Functionally, it has been shown to act trophically on corneal wound healing and to participate in the irritative response in lower mammals, a model for neurogenic inflammation, where it mediates the noncholinergic nonadrenergic contraction of the sphincter muscle. Over the last three decades, the interest has extended to investigate the presence and distribution of other neuropeptides including calcitonin gene-related peptide, vasoactive intestinal polypeptide, neuropeptide Y, pituitary adenylate cyclase-activating polypeptides, cholecystokinin, somatostatin, neuronal nitric oxide, galanin, neurokinin A or secretoneurin and important functional results have been obtained for these peptides. This review focuses on summarizing the current knowledge about neuropeptides in the eye excluding the retina and retinal pigment epithelium and to elucidate their potential functional significance.

Changes in the expression of neuropeptide Y (NPY) during maturation of human sympathetic ganglionic neurons: correlations with tyrosine hydroxylase immunoreactivity

Developmental patterns of neuropeptide Y (NPY) and tyrosine hydroxylase (TH)-immunoreactivities (IR) were investigated using the method of indirect immunohistochemistry in the stellate and thoracic sympathetic ganglia of human neonates ranging in gestational age from 24 to 27 weeks (premature group) and from 38 to 41 weeks (mature group). In the paravertebral ganglia of premature neonates a small (up to 7%) population of NPY-IR nerve cells was revealed. With the gestational age increase (a mature group), a marked elevation of the number of NPY-IR ganglionic neurons (up to 41%) was noted. In contrast, in the sympathetic ganglia of premature neonates almost all the neurons were tyrosine hydroxylase immunoreactive and any change in pattern during maturation was insignificant. The results demonstrate an age-related increase of neuropeptide Y-immunoreactivity in human paravertebral ganglia during maturation, and suggest that peptidergic co-transmission arises later in development than do the classical autonomic messengers. Adaptability of the fetus to a new external environment at birth demands a qualitatively new activity level of the autonomic nervous system, and this is provided side by side with the classical messengers noradrenaline and acetylcholine by the co-transmitter and modulating role of the neuropeptides. The appearance of neuropeptide Y in the principal sympathetic ganglionic neurons defines not only a qualitatively new level in the functional regulation of target organs at birth, but serves as an index of neonatal maturity.

Postnatal development of the rat intrinsic cardiac nervous system: a confocal laser scanning microscopy study in whole-mount atria

We used confocal laser scanning microscopy and fluorescent immunohistochemistry to study the developmental pattern and distribution of specific neuronal phenotypes within the intrinsic cardiac nervous system in whole-mount atrial preparations from newborn to 5 week old rats. Individual ganglia and neuronal cell bodies were localized by means of two general neuronal markers: protein gene product 9.5 (PGP) and microtubule-associated protein two (MAP). In rats < or =2 weeks old there were two main subpopulations of intrinsic neurons located in the intraatrial septum and around the origin of the superior vena cava. The more abundant was a population of strongly tyrosine hydroxylase (TH) immunoreactive (IR) neurons (10-40 microm in diameter) most of which were also PGP-IR. The second, less numerous (approximately 60-70% than the TH-IR group) type of neurons exhibited ChAT-IR which colocalized with MAP-IR. Towards the end of the second postnatal week and during the third, the ganglia containing these neurons became more numerous and their localization also included tissues around the origins of the inferior vena cava and the pulmonary veins, as well as both atrial walls close to the AV junction. During the second and third postnatal weeks, when the extrinsic innervation of the adrenergic and cholinergic phenotypes largely increases, the intrinsic innervation also changed greatly, and around the 21st postnatal day it appeared to acquire mature characteristics. The TH-IR neurons changed their characteristics and formed two types of ganglia. The larger ganglia containing large cells (20-40 microm in diameter) expressed TH-IR mostly close to their inner body surface (approximately 80-90% of identified neurons). Most of these neurons also expressed neuropeptide Y (NPY)-IR, specifically around their nuclei. The second type of small strongly TH-IR neurons (approximately 10% of all identified neurons) were contained in smaller groups (20-50 cells) which were usually embedded into much larger ganglia (100-400 cells), containing large (20-50 microm) neurons. Unlike all other intrinsic neurons, these small TH-IR cells did not exhibit any PGP-IR or MAP-IR. The number of ChAT-IR neurons increased at this stage, reaching approximately 90% of the neurons identified by the general neuronal markers. These neurons were surrounded by a rich network of cholinergic varicose nerve fibers, some of which were likely of an extrinsic origin. We have also identified relatively small ganglia expressing immunoreactivity to vasoactive intestinal polypeptide (VIP), and to substance P (SP). The presented data indicate that the phenotypes of intrinsic neurons in the rat heart change greatly during the first month of postnatal development. This may be at least partially related to the development and maturation of functional extrinsic nervous control of the heart.

Localization, regulation and functions of neurotransmitters and neuromodulators in cervical sympathetic ganglia

Cervical sympathetic ganglia represent a suitable model for studying the establishment and plasticity of neurochemical organization in the nervous system since sympathetic postganglionic neurons: (1) express several neuromediators, i.e., short acting transmitters, neuropeptide modulators and radicals, in different combinations; (2) receive synaptic input from a limited number of morphologically and neurochemically well-defined neuron populations in the central and peripheral nervous systems (anterograde influence on phenotype); (3) can be classified morphologically and neurochemically by the target they innervate (retrograde influence on phenotype); (4) regenerate readily, making it possible to study changes in neuromediator content after axonal lesion and their possible influence on peripheral nerve regeneration; (5) can be maintained in vitro in order to investigate effects of soluble factors as well as of membrane bound molecules on neuromediator expression; and (6) are easily accessible. Acetylcholine and noradrenaline, as well as neuropeptides and the recently discovered radical, nitric oxide, are discussed with respect to their localization and possible functions in the mammalian superior cervical and cervicothoracic (stellate) paravertebral ganglia. Furthermore, mechanisms regulating transmitter synthesis in sympathetic neurons in vivo and in vitro, such as soluble factors, cell contact or electrical activity, are summarized, since modulation of transmitter synthesis, release and metabolism plays a key role in the neuronal response to environmental influences.

Release of calcitonin gene-related peptide in guinea pig inferior mesenteric ganglion

Neurons of the guinea pig IMG are surrounded by nerve fibers containing CGRP-like immunoreactivity (LI). The purpose of this study was to determine whether colonic distension releases CGRP-LI in the IMG and whether opioid peptides and neurotensin(8-13) [NT(8-13)] modulate its release. Colonic distension released CGRP-LI. Methionine-enkephalin acted through mu and/or delta receptors to block release. NT(8-13) had no effect on release of CGRP-LI. Capsaicin pretreatment reduced the content of CGRP-LI in the IMG by 37%. Colonic distension did not release CGRP-LI from capsaicin-insensitive fibers. The data suggest that colonic distension releases CGRP-LI material from capsaicin-sensitive nerves and that enkephalins modulate release of CGRP-LI.

Development of peptide-containing nerves in the human fetal vas deferens and seminal vesicle

OBJECTIVE

To use immunohistochemical methods to study the developing autonomic innervation of the human fetal vas deferens and seminal vesicle.

MATERIAL AND METHODS

Thirteen pre-natal specimens ranging in gestational age from 13 to 30 weeks were acquired following abortion or miscarriage. The overall innervation of each specimen was visualized using protein gene product 9.5 (PGP), a general nerve marker, while the onset and development of specific neuropeptide-containing sub-populations were investigated using antisera to neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), substance P (SP), calcitonin gene related peptide (CGRP), bombesin (BOM), somatostatin (SOM), and met-enkephalin (ENK). In addition the occurrence and distribution of presumptive noradrenergic nerves was studied using antisera to dopamine-beta-hydroxylase (D beta H) and tyrosine hydroxylase (TH).

RESULTS

At 13 weeks numerous PGP, D beta H, TH, NPY and ENK immunoreactive (-IR) nerve trunks were present in the adventitia of the vas deferens and seminal vesicle but at this stage nerve fibres were not present in the smooth muscle coat of either organ. By 17 weeks, fine PGP-, D beta H, and TH-IR nerve fibres had penetrated the outer aspect of the muscle coat of the seminal vesicle but not the vas deferens. At 20 weeks a branching network of PGP-, D beta H- and TH-IR nerve fibres occurred throughout the full thickness of the muscle coat of the seminal vesicle while similar nerves were present only in the outer half of the muscle coat of the vas deferens. At 23 weeks the full thickness of the muscle coat of the vas deferens was richly innervated by a branching plexus of PGP-IR nerves. Many of these adventitial and intramuscular nerves were immunoreactive for D beta H or TH while some were immunoreactive for either NPY or ENK. Occasional adventitial nerves were immunoreactive for SP or CGRP, these being first observed at 20 weeks. VIP-IR nerves were extremely rare in the muscle coat of either organ, being first observed at 17 weeks in the seminal vesicle and at 20 weeks in the vas deferens where they mainly formed perivascular plexuses. PGP-IR nerves were first observed in the submucosa of the seminal vesicle at 20 weeks and in the vas deferens at 21 weeks. Some of these nerves were perivascular in location while other formed a subepithelial plexus which increased in density with increasing gestational age. At 22 weeks of gestation some of the submucosal nerves were immunoreactive for SP or NPY, while at 30 weeks NPY-IR nerves formed the majority of subepithelial nerves. Occasional VIP-IR subepithelial nerves were first observed at 26 weeks but were extremely rare even at 30 weeks. Submucosal nerves immunoreactive for CGRP, D beta H, TH or ENK did not occur in any of the specimens examined.

CONCLUSION

(i) From 13 weeks gestation autonomic nerves develop in the muscle coat of the fetal seminal vesicle and vas deferens, being denser in the seminal vesicle than the vas deferens up to 23 weeks gestation. (ii) The majority of the intramuscular nerves in either organ contain D beta H, TH, NPY and ENK and are presumably noradrenergic in type. (iii) A subepithelial nerve plexus develops around 20 weeks gestation and contains NPY but not VIP, unlike the adult organs. (iv) Scattered neuroendocrine cells immunoreactive for SOM are present in the mucosa of the seminal vesicle from 23 weeks of gestation.

Comparison of immunohistochemical localization of [Met5]enkephalin-Arg6-Gly7-Leu8, [Met5]enkephalin, neuropeptide Y and vasoactive intestinal polypeptide in the superior cervical ganglion of the rat

The localization of [Met5]enkephalin-Arg6-Gly7-Leu8 and [Met5]enkephalin immunoreactivities was studied in the rat superior cervical ganglion. The distribution of these enkephalin-containing peptides in the ganglion was correlated to that of neuropeptide Y and vasoactive intestinal polypeptide. Three different populations of peptide-containing postganglionic neurons were demonstrated. (1) A minor population (10-20%) of principal neurons was immunoreactive for [Met5]enkephalin-Arg6-Gly7-Leu8 but not immunoreactive for neuropeptide Y nor vasoactive intestinal polypeptide. (2) The major population (about 50-70%) was immunoreactive for neuropeptide Y but not for [Met5]enkephalin-Arg6-Gly7-Leu8. (3) Few vasoactive intestinal polypeptide-immunoreactive principal neurons (less than 2% of all principal neurons) were observed in the ganglion. All vasoactive intestinal polypeptide-immunoreactive neurons were also immunoreactive for neuropeptide Y but not for [Met5]enkephalin-Arg6-Gly7-Leu8. [Met5]enkephalin-Arg6-Gly7-Leu8- and [Met5]enkephalin-immunoreactive nerve fibers had a similar distribution. These enkephalin immunoreactive nerve fibers were seen to enclose both neuropeptide Y-containing principal neurons and neurons devoid of neuropeptide Y immunoreactivity. Furthermore, there were enkephalin-immunoreactive fiber baskets around vasoactive intestinal polypeptide-immunoreactive neurons and sometimes also around solitary enkephalin-immunoreactive neurons. Previously reported diverse role of enkephalins in the rat superior cervical ganglion is supported by this study.

Patterns of neuronal colocalisation of tyrosine hydroxylase, neuropeptide Y, vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P in human ureter

The patterns of colocalisation of neuropeptides, tyrosine hydroxylase (TH), and protein gene product 9.5 (PGP), were studied in nerve fibres supplying the upper and lower human ureter using a double labelling immunofluorescence technique. The majority (85%-95%) of nerve fibres within the ureter contained neuropeptide Y-like immunoreactivity (NPY-LIR), in combination with other peptides. Approximately 52%-63% of the total ureteral innervation was made up of NPY-LIR fibres also expressing TH-LIR, while 21%-42% of fibres contained NPY-LIR in combination with vasoactive intestinal polypeptide (VIP)-LIR. These two immunochemically defined classes did not overlap, since TH- and VIP-LIR were never present within the same nerve fibre. Other minor populations of neurones included those containing calcitonin gene-related peptide (CGRP)-LIR in combination with substance P (SP)-LIR (4%-17%) and those without SP (5%). Rare coexistences were also noted between CGRP- and VIP-LIR (1%-2%), CGRP- and NPY-LIR (< or = 1%), and CGRP- and TH-LIR (< 1%). Regional differences in innervation were found. There were fewer of each class of nerve fibres in the upper ureter compared to the lower ureter. In addition, the proportion of VIP/NPY-LIR fibres of the total innervation was less in the upper ureter, where they were very sparse. Differences in the distribution to various tissue targets were also observed. In the lower ureter, TH/NPY-LIR fibres were localised predominantly to the outer muscle fascicles and adventitia, while VIP/NPY immunoreactive nerves supplied the submucosa and inner smooth muscle fascicles. Both of these populations were also found around blood vessels. A population of presumptive sensory fibres expressing CGRP/SP-LIR were typically present immediately beneath the urinary epithelium and around blood vessels, and only very rarely within muscle fascicles. The finding that TH/NPY- and VIP/NPY-LIR fibres innervate different layers of the ureter raises the possibility that the muscle layers of the ureter may be independently controlled.

Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications

Neuropeptides are ubiquitous in the sympathetic system and modulate transmission at the levels of the intermediolateral cell column, sympathetic ganglia, and neuroeffector junctions. Several neuropeptide-containing pathways from the hypothalamus and medulla modulate excitability of preganglionic neurons. Neuropeptides coexist with norepinephrine or acetylcholine in subpopulations of chemically coded, target-specific sympathetic ganglion neurons. Neuropeptide Y is colocalized in adrenergic vasoconstrictor neurons, whereas vasoactive intestinal polypeptide is colocalized in cholinergic sudomotor neurons. Neuropeptide expression is plastic; during development, neurons that switch from a noradrenergic to a cholinergic phenotype increase expression of vasoactive intestinal polypeptide, somatostatin, and substance P. Preganglionic inputs increase neuropeptide Y and inhibit substance P expression. Sympathetic denervation produces sprouting of sensory fibers containing substance P and calcitonin gene-related peptide in target tissues. Neuropeptides from preganglionic fibers (e.g., enkephalin) and primary afferents (e.g., substance P, vasoactive intestinal polypeptide) modulate transmission in sympathetic ganglia. Neuropeptide Y produces vasoconstriction, prejunctional inhibition of norepinephrine release, and postjunctional potentiation of norepinephrine effects. Plasma neuropeptide Y increases during intense sympathoexcitation, hypertension, and pheochromocytoma. Dystrophic neurites containing neuropeptide Y occur in human sympathetic ganglia during aging, diabetes, and dysautonomia. Sympathetic neuropeptides may thus have important clinical implications.

An immunohistochemical study of the innervation of the ureterovesical junction in infancy and childhood

OBJECTIVE

To use histological and immunohistochemical methods to study the structure and innervation of the human ureterovesical junction (UVJ).

MATERIALS AND METHODS

A series of 24 post-natal specimens taken from patients ranging in age from 1 month to 6 years were examined. Routine histological slides were stained with Masson's trichrome. In addition, an indirect immunohistochemical method was used to study the occurrence and distribution of nerves immunoreactive for the neuropeptides vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY), substance P (SP) and calcitonin gene-related peptide (CGRP). Immunoreactivity to tyrosine hydroxylase (TH), dopamine-B-hydroxylase (DBH) and to protein gene product (PGP) 9.5, a general nerve marker, were also studied.

RESULTS

The UVJ comprised a ureteric muscle component (the intramural ureter) and a detrusor component (the immediately adjacent region of the urinary bladder). In the majority of specimens a third or intermediate layer was also present. This additional component consisted of tightly-packed smooth muscle cells which formed an incomplete layer that partially surrounded the juxta-vesical and intramural parts of the ureter. Numerous PGP-, VIP-, NPY, DBH- and TH- like immunoreactive (-LIR) nerves were associated with the smooth muscle bundles which comprised the intramural ureter. Such nerves ran in the connective tissue separating ureteric smooth muscle bundles and rarely coursed amongst individual smooth muscle cell comprising each bundle. SP- and CGRP- containing nerves were rarely observed in association with the intramural ureter and none were detected in the ureteric submucosa. The intermediate muscle layer was richly innervated by PGP-, TH-, DBH- and NPY- containing nerves which ran amongst the smooth muscle cells comprising this layer. VIP-, SP- and CGRP-LIR nerves were not observed within the intermediate layer. The detrusor component of the UVJ was innervated by PGP-, NPY- and VIP-LIR nerves which frequently extended between the smooth muscle cells forming the detrusor muscle bundles. TH-, DBH-, SP- and CGRP-LIR nerve fibres were rarely encountered.

CONCLUSION

These findings indicate that noradrenergic nerves play a major role in the control of the ureteric component of the UVJ. In addition, the present results form baseline morphological data with which to compare the results of future studies on the structure of the UVJ in cases of vesicoureteric reflux.

Distinct subsets of neuropeptide Y-negative principal neurons receive basket-like innervation from enkephalinergic and gabaergic axons in the superior cervical ganglion of adult rats

The distributions of axons immunoreactive for [Leu]- or [Met]enkephalin and GABA were studied in the superior cervical ganglion of adult rats. The antigens were visualized separately and in combination with neuropeptide Y by the immunoperoxidase technique, using reaction end-products of different colors. Similarities and differences were found in the light-microscopic innervation patterns of enkephalin- and GABA-immunoreactive nerve fibers. Both fiber systems were heterogeneously distributed within the superior cervical ganglion, forming denser networks in its rostral part than elsewhere in the ganglion. The appearance of labeled nerve fibers differed in the two systems. Enkephalin-immunoreactive axons exhibited dotted profiles due to a strong immunoreaction in the axonal varicosities as compared with that in the intervaricose segments, whereas GABA-positive fibers were evenly labeled in both parts of the axons. The most marked difference between the innervation patterns from enkephalin- and GABA-immunoreactive axons was the presence of bundles of varicose axons in conjunction with the basket-like aggregation of enkephalin-immunoreactive nerve terminals. The possibility that enkephalins and GABA are co-localized in certain axons was excluded in double-labeling studies, silver intensification being used for the first antigen and the nickel-enhanced diaminobenzidine reaction for the second antigen. Different subsets of principal neurons were richly innervated in a basket-like manner by axons immunoreactive for enkephalins and GABA. Additionally, combined staining with antisera against either enkephalin and neuropeptide Y or GABA and neuropeptide Y revealed that both subsets of principal neurons richly innervated either by enkephalin-immunoreactive or by GABA-immunoreactive axons were devoid of neuropeptide Y immunoreactivity. Thus, the enkephalinergic and GABAergic axons have different subpopulations of neuropeptide Y-negative principal neurons as targets in the superior cervical ganglion. These results provide further evidence that sympathetic ganglion cells can be classified on the basis of their receiving input from different sources.

Ultrastructural localization of neuropeptide Y-immunoreactivity in the axonal reticulum elements, accumulating anterogradely in transected rat sciatic nerve

The detection of dopamine-beta-hydroxylase and cytochrome B561 on the membranes of the axonal reticulum demonstrated that in sympathetic neurons the different compartments of the axonal reticulum participate in the formation of neurosecretory vesicles. In the present study we tried to reveal that the components of the vesicular content are also channeled along the axonal reticulum, by examining whether neuropeptide Y could be localized in elements of the axonal reticulum. Therefore 6 h transected rat sciatic nerve was embedded in glycolmethacrylate and an immunogold labeling was performed. Counterstaining with phosphotungstic acid at low pH selectively contrasted the accumulated axonal reticulum elements and associated granules. In the non-myelinated axons gold labeling was localized on granules and on tubular and granular profiles, demonstrating the presence of neuropeptide Y in the accumulated axonal reticulum elements. This indicates that neuropeptides are indeed transported via the axonal reticulum to the nerve ending and suggests that the accumulation of large dense-cored vesicles at a block is mainly due to local new formation rather than down transport.

Neuropeptide Y-lmmunoreactive Nerve Fibres in the Pineal Gland of the Macaque (Macaca fascicularis)

The distribution of neuropeptide Y (NPY)- and the C-fianking peptide of NPY (CPON)-immunoreactive elements in the pineal gland of the macaque was investigated by means of immunohistochemistry. NPY- and CPON-immunoreactive nerve fibres were located in the precommissural nucleus, around the stria medullaris, and in the posterior commissure. NPY- and CPON-immunoreactive nerve fibres endowed with bulbous varicosities, were traced from the brain via the pineal stalk into the rostral part of the pineal gland. Furthermore, CPON-immunoreactive, and to a lesser extent NPY-immunoreactive nerve fibres, were distributed in the méninges, the choroid plexus and the vasculature related to the pineal organ. Nerve fibres located in the pineal capsule penetrated into the pineal parenchyma, where groups of individual fibres were found most often in an interlobular position. Occasionally, individual nerve fibres dispersed between the pinealocytes were observed. In contrast to the nerve fibres originating from the brain, those originating from the periphery were endowed with smaller immunoreactive nerve terminals. Another apparent difference was that the peripheral nerve fibres innervated only the caudal two-thirds of the gland, whereas the central fibres were found exclusively in the rostral part of the pineal organ. Rarely, positive neuronal-like cells were found in the pineal parenchyma. These results show the presence of a moderate number of NPY- and CPON-immunoreactive nerve fibres within the primate pineal organ and strongly indicate that the primate pineal gland is innervated by NPYergic nerve fibres originating from both a peripheral and a central source.

Presence and regional variation in peptide-containing nerves in the human ureter

The occurrence, distribution and regional variation of neurones immunoreactive for the neuropeptides, vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY), enkephalin (ENK), calcitonin gene-related peptide (CGRP), and substance P (SP) were investigated in human ureters by indirect immunohistochemistry. In addition, immunoreactivities to tyrosine hydroxylase (TH), a marker of noradrenergic neurones and to protein gene product (PGP) 9.5, a general marker of neurones, were also studied. Neurones displaying PGP-, NPY-, VIP- and TH-like immunoreactivity (-LIR) provided a rich innervation to the smooth muscle and blood vessels of the ureter, where they formed dense muscular and perivascular nerve plexuses. In contrast, there was only a moderate to sparse innervation by SP and CGRP-LIR neurones, most of which were distributed to blood vessels and to the sub mucosal layer, and only rarely to smooth muscle bundles. No ENK-LIR was detected in this study. Nerve fibre bundle densities were estimated for each of the localized neurochemicals according to a method described. NPY-LIR nerve fibre bundles were found to account for 80% of the total nerve fibre bundles (i.e. PGP-LIR) in the ureter. On the other hand, TH-LIR and VIP-LIR nerve fibre bundles each accounted for 50% of the total ureteral innervation, whereas SP- and CGRP-LIR nerve fibre bundles each comprised 20% of the total innervation. The abundance and pattern of tissues innervated by these immunoreactive neurones is consistent with the view that some of these neuropeptide substances co-exist with other peptide substances and/or with other known neurotransmitters, such as noradrenaline or acetylcholine. A gradient of innervation was found to exist for all the neurochemicals demonstrated in the ureter, whereby the lower ureter receives a greater density of innervation than the upper ureter. This finding suggests the human ureter is primarily innervated by fibres arising from or via the lower pelvis, i.e. the pelvic plexus. It also supports the view that the lower ureter may perform an important physiological role, such as coordinating the tone of this region during bladder filling and emptying.

Neuropeptides in the human superior cervical ganglion

Superior cervical ganglia from 7 human cadavers (3-7 h post mortem) were immunostained for tyrosine hydroxylase (TH), dopamine-beta-hydroxylase (DBH) and 14 different neuropeptides. The results show that ganglionic cells contain TH, DBH, neuropeptide Y (NPY), somatostatin, vasoactive intestinal polypeptide (VIP) and calcitonin gene-related peptide (CGRP). These substances were present predominantly within large ganglionic cells. Inside the ganglion, the number and topographical distribution of various types of immunoreactive cells differed from one another. NPY and CGRP immunoreactivities were found in some TH-positive cells, but that co-localization never exceeded the 30% of the TH cells. Leu-enkephalin showed a weak immunoreactivity, which was restricted to fibers or varicosities. Neuropeptides like substance P, dynorphin A and B, cholecystokinin, galanin, corticotropin-releasing factor, thyrotropin-releasing hormone, angiotensin II and neurotensin showed no immunoreactivity in the human superior cervical ganglion.

Segmental distribution of colonic neuropeptides in Hirschsprung's disease

Despite continued research, the pathophysiologic mechanism responsible for functional obstruction in the aganglionic segment of bowel in Hirschsprung's disease remains controversial. Narrowing of the affected segment is thought by many investigators to be the result of loss of intrinsic inhibitory innervation. For this hypothesis to be consistent, inhibitory neuropeptides should be present in the dilating, transitional segment of bowel. In order to quantitate reported changes in peptidergic nerve staining in Hirschsprung's disease, we measured concentrations of five neuropeptides (vasoactive intestinal peptide, peptide histidine-methionine, met5-enkephalin, substance P and bombesin-like immunoreactivity) by radioimmunoassay in the affected segments of bowel from six patients with Hirschsprung's disease. Tissue extracts were prepared using gut obtained at surgery from the: (1) constricted, aganglionic segment, (2) dilating, aganglionic transitional segment and (3) dilated, proximal ganglionic segment. Concentrations of vasoactive intestinal peptide, peptide histidine-methionine, substance P and met5-enkephalin were significantly reduced in both the muscularis externa and the mucosal-submucosal layers from the constricted aganglionic segment. By contrast, concentrations of the candidate inhibitory neuropeptides, vasoactive intestinal peptide and peptide histidine-methionine, were minimally reduced in the dilating, aganglionic transitional segment. These results are consistent with the hypothesis that constriction of the aganglionic segment is due to loss of intrinsic inhibitory innervation. Concentrations of bombesin-like immunoreactivity were similar in the three segments of human gut, suggesting the presence of this immunoreactive neuropeptide in extrinsic nerve fibers.

Neuropeptide Y: an endogenous inhibitor of norepinephrine-stimulated melatonin secretion in the rat pineal gland

The biosynthesis of the hormone melatonin (MEL) by the mammalian pineal gland has been thought to be regulated strictly by stimulatory factors, most predominantly norepinephrine (NE), released from the sympathetic nerve fibers which heavily innervate the gland. Evidence from many investigators suggests that sympathetic fibers may colocalize other neuroactive factors in addition to NE. One of these factors is neuropeptide Y (NPY), which has been found in the nerve fibers of the pineal gland. The present study sought to explore potential interactions between NE and NPY in the regulation of pineal MEL secretion. Specific, saturable, and reversible binding of 125I-NPY to intact cultured pinealocytes was measured with an affinity constant of 1 nM and an NPY binding site density of 0.04 pmol/mg of protein. In addition, cell culture studies revealed that NPY represents a potent (IC50 of 0.4 nM) endogenous inhibitor of NE-stimulated MEL secretion. However, this inhibition is accompanied by only a modest reduction (35%) of cyclic AMP accumulation. These findings reinforce the view that the mammalian pineal gland, which appears to integrate both inhibitory as well as stimulatory signals, is an important model of autonomic function, particularly in the context of biological rhythmicity.